Tag Archives: NagaCorp

  • “One of the best biotech companies that I’ve ever looked at…” Plus some updates for the Friday File

    I’ve got a big ol’ pile of updates and thoughts about a dozen or so companies to get to, but we’re going to start with a teaser solution today. Paul Mampilly of Agora Financial’s FDA Trader apparently sent around a teaser note to his own subscribers (I say “apparently” because I’ve only seen the cut-and-paste […]

  • Naga Interview

    Just wanted to note a rare publicity moment for Nagacorp — results have been good as they continue to draw in regional gamblers to Cambodia. Their Chair got an interview on one of CNBC’s Asia shows here, long enough to give a good introduction to the company and update on their strategy and plans. Still […]

  • Gaga over Naga

    You may have noticed, but since news about Hong Kong-listed stocks doesn’t often trickle to the top of the Yahoo Finance feed I thought I’d post it here to make sure: Shares of Nagacorp, which was an “Idea of the Month” pick a long time ago and which has performed extremely well over the past […]

  • This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.